This intermediate effect could be explained by the diversity and opposing effects of the CD4+ T cell subsets present in the tumor microenvironment, including anti-tumoral Th1 cells and immunosuppressive T regulatory (Treg) cells (35). The gene discussed is CD4; the disease is neoplasm.